We are excited about the data and plan to submit the data for publication and peer reviewed medical journal in the near term.

$AVXL Australia trial data meets the gold standard.

$AVXL - Alz Topline Data was solid ..

Efficacy is likey overwhelming after seeing 👀 data details!

$AVXL I am extremely bullish on the data .. the FDA can ask any sorts of questions

I'm looking forward to seeing the long term AD data on ANVS and have the feeling it's going to end up being the best in class AD treatment as well.

Now DATA met expectations.

Also clint said every time Blarcamesine data comes back it looks better and better. .

Anavex has significant 4 years of ph2/3 safety data with safety back to 2013 for Blarcamesine .. anavex has full 3 endpoint trial and a placebo .. it's obvious Anavex wins!!

So I think the data so far was encouraging,

See 20+ , low float , P/E ratio , EPS , positive data .

3.67 cash per share and $20+ PT's. Not to mention, consistency with positive studies and data.

$BXRX must be good phase 2 data

This is accurate up to date short data.

Solid data !

Get Ready for better data coming !

we just today got a great CPI data as per expectations.

$BABA $eh $VNET $lu $MLCO tomorrow’s CPI data comes out to be better than expected, everything will go up.

VNET is one of the largest data centers companies in China and as investors are getting more comfortable investing in China this can rocket high very soon.

Big data analytics winning !

$BABA Market seems bullish before the CPI data release tomorrow, latest economic calendar shows all of the critical economic updates for tomorrow, that can impact the overall market and BABA stock https://thefinanceheadline.com/economic-calendar/

$GOOGL $BABA $UPST $AAPL THE DATA LOOKING GREAT AS EXPECTED.